CONTACT US
CAREERS
Home
ABOUT US
MANAGEMENT
BOARD OF DIRECTORS
PRODUCT PIPELINE
UX001 SA-ER
FOR PATIENTS
GNE MYOPATHY (HIBM)
MPS 7
Long-chain FAOD
NEWS
INVESTORS
News and Press Releases
Investor Information
Ultragenyx is a privately held company. If you are an accredited investor looking for specific information, please complete the information below, along with the nature of your interest in Ultragenyx.
Contact Information
*
First Name
*
Last Name
Company
Title
Phone
Message
*
Email
Press Releases
Company Presentation at 2013 BioCentury Future Leaders Conference
Copyright 2011, Ultragenyx™ Pharmaceutical
Privacy Policy
Login
Powered by